T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice

Journal of Experimental Medicine

Volumn 189, Issue 5, 1999, Pages 803-810

  Schüler, Thomas ^a   Qin, Zhihai ^a   Ibe, Sabrina ^a   Noben Trauth, Nancy ^b   Blankenstein, Thomas ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Interleukin 4; Interleukin 4 deficient mice; T cell immunity; Tumor vaccination

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ADENOCARCINOMA; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HELPER CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN DEFICIENCY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR IMMUNITY; VACCINATION;

ADENOCARCINOMA; ANIMALS; CARCINOMA; COLONIC NEOPLASMS; CYTOTOXICITY, IMMUNOLOGIC; DISEASE-FREE SURVIVAL; FEMALE; INTERLEUKIN-4; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS;

EID: 0345628580     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.5.803     Document Type: Article

References (48)

1. Van den Eynde, B., and P. van der Bruggen. 1997. T cell defined tumor antigens. Curr. Opin. Immunol. 9:684-693.
2. Schreiber, H. 1993. Tumor immunology. In Fundamental Immunology, Third Edition. W.E. Paul, editor. Raven Press, New York. 1143-1178.
3. Ossendorp, F., E. Mengede, M. Camps, R. Filius, and C.J. Melief. 1998. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J. Exp. Med. 187:693-702.
4. Blankenstein, T., S. Cayeux, and Z. Qin. 1996. Genetic approaches to cancer immunotherapy. Rev. Physiol. Biochem. Pharmacol. 129:1-49.
5. Hock, H., M. Dorsch, U. Kunzendorf, K. Überla, Z. Qin, T. Diamantstein, and T. Blankenstein. 1993. Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant. Cancer Res. 53:714-716.
6. Cavallo, F., F. Di Pierro, M. Giovarelli, A. Gulino, A. Vacca, A. Stoppacciaro, M. Forni, A. Modesti, and G. Forni. 1993. Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma. Cancer Res. 53:5067-5070.
7. Uckert, W., T. Kammertöns, K. Haack, Z. Qin, J. Gebert, D.J. Schendel, and T. Blankenstein. 1998. Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo. Hum. Gene Ther. 9:855-865.
8. Qin, Z., G. Richter, T. Schüler, S. Ibe, X. Cao, and T. Blankenstein. 1998. B cells inhibit induction of T cell-dependent tumor immunity. Nat. Med. 4:627-630.
9. Bevan, M.J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143: 1283-1288.
10. Huang, A.Y., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHG class I-restricted tumor antigens. Science. 264:961-965.
11. Cayeux, S., G. Richter, G. Noffz, B. Dörken, and T. Blankenstein. 1997. Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation. J. Immunol. 158:2834-2841.
12. + T cell help. J. Exp. Med. 186:65-70.
13. + T-helper and a T-killer cell. Nature. 393:474-478.
14. Bennett, S.R., F.R. Carbone, F. Karamalis, R.A. Flavell, J.F. Miller, and W.R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 393:478-480.
15. Schoenberger, S.P., R.E. Toes, E. van der Voort, R. Offringa, and C.J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 393:480-483.
16. Mosmann, T.R., H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357.
17. Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature. 383:787-793.
18. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:275-283.
19. Fitch, F.W., M.D. McKisic, D.W. Lancki, and T.F. Gajewski. 1993. Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 11:29-48.
20. Sher, A., and R.L. Coffman. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:385-409.
21. Allen, J.E., and R.M. Maizels. 1997. Th1-Th2: reliable paradigm or dangerous dogma? Immunol. Today. 18:387-392.
22. Toellner, K.M., S.A. Luther, D. Sze, R. Choy, D.R. Taylor, I. MacLennan, and H. Acha-Orbea. 1998. T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J. Exp. Med. 187:1193-1204.
23. Platzer, C., G. Richter, K. Überla, W. Müller, H. Blocker, T. Diamantstein, and T. Blankenstein. 1992. Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction. Eur. J. Immunol. 22: 1179-1184.
24. Noble, A., and D.M. Kemeny. 1995. Interleukin-4 enhances interferon-gamma synthesis but inhibits development of interferon-gamma-producing cells. Immunology. 85:357-363.
25. Kamogawa, Y., L.A. Minasi, S.R. Carding, K. Bottomly, and R.A. Flavell. 1993. The relationship of IL-4- and IFN gamma-producing T cells studied by lineage ablation of IL-4-producing cells. Cell. 75:985-995.
26. Noben-Trauth, N., G. Köhler, K. Burki, and B. Ledermann. 1996. Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic Res. 5:487-491.
27. Noben-Trauth, N., P. Kropf, and I. Müller. 1996. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science. 271:987-990.
28. Nanni, P., C. de Giovanni, P.L. Lollini, G. Nicoletti, and G. Prodi. 1983. TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma. Clin. Exp. Metastasis. 1:373-380.
29. Corbett, T.H., D.J. Griswold, B.J. Roberts, J.C. Peckham, and F.J. Schabel. 1975. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res. 35:2434-2439.
30. Hu, L.J., J. Ohara, C. Watson, W. Tsang, and W.E. Paul. 1989. Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S).J. Immunol. 142:800-807.
31. Kiessling, R., G. Petranyi, G. Klein, and H. Wigzel. 1975. Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line. Int. J. Cancer. 15:933-940.
32. Huang, A.Y., P.H. Gulden, A.S. Woods, M.C. Thomas, C.D. Tong, W. Wang, V.H. Engelhard, G. Pasternack, R. Cotter, D. Hunt, et al. 1996. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc. Natl. Acad. Sci. USA. 93:9730-9735.
33. Rao, J.B., R.S. Chamberlain, V. Bronte, M.W. Carroll, K.R. Irvine, B. Moss, S.A. Rosenberg, and N.P. Restifo. 1996. IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. J. Immunol. 156:3357-3365.
34. + T cells. J. Immunol. 158:1085-1094.
35. Bachmann, M.F., H. Schorle, R. Kühn, W. Müller, H. Hengartner, R.M. Zinkernagel, and I. Horak. 1995. Antiviral immune responses in mice deficient for both interleukin-2 and interleukin-4. J. Virol. 69:4842-4846.
36. + cells but markedly decreased helper cell activity in mice lacking CD4. Nature. 353:180-184.
37. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-8063.
38. Platzer, C., G. Richter, K. Überla, H. Hock, T. Diamantstein, and T. Blankenstein. 1992. Interleukin-4-mediated tumor suppression in nude mice involves interferon-gamma. Eur. J. Immunol. 22:1729-1733.
39. Dighe, A.S., E. Richards, L.J. Old, and R.D. Schreiber. 1994. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity. 1:447-456.
40. + T helper type 1 cell responses to Candida albicans. J. Exp. Med. 187:307-317.
41. Noffz, G., Z. Qin, M. Kopf, and T. Blankenstein. 1998. Neutrophils but not eosinophils are involved in growth suppression of IL-4-secreting tumors. J. Immunol. 160:345-350.
42. Qin, Z., G. Noffz, M. Mohaupt, and T. Blankenstein. 1997. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells. J. Immunol. 159:770-776.
43. Lange, C., T. Schüler, and T. Blankenstein. 1998. Interleukin 4 gene-defective mice reconstituted with wild-type bone marrow fail to produce normal immunoglobulin E levels. J. Exp. Med. 187:1487-1493.
44. Bosco, M., M. Giovarelli, M. Forni, A. Modesti, S. Scarpa, L. Masuelli, and G. Forni. 1990. Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and in-duce a tumor-specific immune memory. J. Immunol. 145: 3136-3143.
45. Urban, J., N. Noben-Trauth, D.D. Donaldson, K.B. Madden, S.C. Morris, M. Collins, and F.D. Finkelman. 1998. IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity. 8:255-264.
46. Barner, M., M. Mohrs, F. Brombacher, and M. Kopf. 1998. Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr. Biol. 8:669-672.
47. von der Weid, T., M. Kopf, G. Köhler, and J. Langhorne. 1994. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur. J. Immunol. 24:2285-2293.
48. Kanagawa, O., B.A. Vaupel, S. Gayama, G. Koehler, and M. Kopf. 1993. Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Science. 262:240-242.